Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  caspofungin acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: 00-085, MSKCC-00085, MERCK-026-01, NCI-G00-1898, NCT00008359
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 months and over
Sponsor: Other
Protocol IDs: MK-0991-062, 2008_013, NCT00717860
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-65041, EUDRACT-2004-002944-90, NCT00110045
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 17 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0991-043, Formerly-0404CCAI, MK0991-043, 2004_100, NCT00082524
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 2 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0991-044, Formerly-0404ETPP, MK0991-044, 2004_101, NCT00082537
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Uni-Koeln-687, 2006-001936-30, NCT00404092
Prophylaxis of Fungal Invasive Infections in Leukemia
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-004432-70, NCT00501098
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UKW-Inf-001, 2009-015159-26, NCT01318148
Caspofungin Acetate in Treating Children With Fever and Neutropenia
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 2 to 17
Sponsor: NCI
Protocol IDs: CDR0000068564, NCI-01-C-0084C, NCT00020527
Start Over